Jack Lawler
Technik-/Wissenschafts-/F&E-Leiter bei CHEMOMAB THERAPEUTICS LTD.
Profil
Jack Lawler is currently the VP-Global Clinical Development Operations at Chemomab Therapeutics Ltd.
He previously worked as the VP-Clinical Operations & Data Management at Goldfinch Bio, Inc. Mr. Lawler completed his undergraduate degree at Rosemont College.
Aktive Positionen von Jack Lawler
| Unternehmen | Position | Beginn |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Technik-/Wissenschafts-/F&E-Leiter | 04.01.2022 |
Ehemalige bekannte Positionen von Jack Lawler
| Unternehmen | Position | Ende |
|---|---|---|
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Jack Lawler
| Rosemont College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
